Key facts
- This page summarizes Patrick Machado's Form 3 filing for Roivant Sciences Ltd. (ROIV).
- 0 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 01 Oct 2021, 17:43.
Patrick Machado - 01 Oct 2021 Form 3 Insider Report for Roivant Sciences Ltd. (ROIV)
- Reporting relationship
- Director
- Issuer ticker
- ROIV
- Reported as of
- 01 Oct 2021
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 01 Oct 2021, 17:43:55 UTC
- Prior SEC filing
- 25 Jun 2021
- Next SEC filing
- 14 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Jo Chen, as Attorney-in-Fact for Patrick Machado
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Patrick Machado filed Form 3 for Roivant Sciences Ltd. (ROIV) on 01 Oct 2021.
Change
- Previous filing in this sequence was filed on 25 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ROIV
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Oct 2021
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 170,167
- Exercise price
- $5.19
- Footnotes
- F1
ROIV
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Oct 2021
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 109,732
- Exercise price
- $7.43
- Footnotes
- F1
ROIV
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Oct 2021
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 109,732
- Exercise price
- $11.19
- Footnotes
- F2, F5
ROIV
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Oct 2021
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 109,732
- Exercise price
- $12.68
- Footnotes
- F3, F5
ROIV
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Oct 2021
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 109,732
- Exercise price
- $10.00
- Footnotes
- F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Award of stock options to purchase Common Shares that is fully vested.
Footnote F2
Award of stock options to purchase Common Shares with a vesting commencement date of November 30, 2018.
Footnote F3
Award of stock options to purchase Common Shares with a vesting commencement date of November 30, 2019.
Footnote F4
Award of stock options to purchase Common Shares with a vesting commencement date of December 27, 2019.
Footnote F5
Awards of stock options to purchase Common Shares vest and become exercisable (i) 33% on the first anniversary of the applicable vesting commencement date and (ii) in 24 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.
SEC remarks
Exhibit 24 - Power of Attorney